| View |
DRP-1557-06_PI_01.pdf
|
DRP-1557-06
|
Betahistine Dihydrochloride
|
None
|
16 mg
|
Tablet
|
Anti-Vertigo
|
Synmedic Laboratories
|
India
|
CLIDP Conversion
|
27 February 2023
|
04 October 2027
|
| View |
DRP-8449_PI_01.pdf
|
DRP-8449
|
Tranexamic acid
|
HEMOSTAN
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (IM/IV)
|
Antifibrinolytic (Amino Acid)
|
Amherst Parenterals, Inc
|
Philippines
|
Renewal
|
05 April 2022
|
16 September 2027
|
| View |
|
DRP-13508-01
|
Etoricoxib
|
Myox
|
120 mg
|
Film-Coated Tablet
|
Non-steroid Anti-inflammatory and Anti-rheumatic Product (Coxib)
|
KRKA, d.d., Novo Mesto
|
|
CLIDP Conversion
|
23 June 2023
|
02 March 2028
|
| View |
|
DRP-13510-01
|
Etoricoxib
|
Myox
|
90 mg
|
Film-Coated Tablet
|
Non-steroid Anti-inflammatory and Anti-rheumatic Product (Coxib)
|
KRKA, d.d., Novo Mesto
|
Slovenia
|
CLIDP Conversion
|
30 May 2023
|
02 March 2028
|
| View |
DRP-14219_PI_01.pdf
|
DRP-14219
|
Salbutamol + Carbocisteine
|
Solmux Broncho
|
2 mg / 500 mg per 5 mL
|
Suspension
|
Bronchodilator / Mucolytic
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
22 November 2024
|
24 January 2030
|